Login:
 
Lockyer M. Gastric bypass induces remission in type 2 diabetes patients with mild-moderate obesity. Practitioner 2016;260 (1795):10

Gastric bypass induces remission in type 2 diabetes patients with mild-moderate obesity

01 Aug 2016Pais-up subscribers

The CROSSROADS randomised controlled trial of Roux-en-Y gastric bypass (RYGB) versus intensive lifestyle and medical intervention has demonstrated better rates of type 2 diabetes remission in patients with mild-moderate obesity treated with bariatric surgery in this US study. This study used a well informed population-based sample, and included patients with a BMI < 35 kg/m2. The 60% figure for diabetes remission is in line with findings from a UK national registry of more than 3,000 diabetes patients who were operated on between 2011 and 2013, which showed 65% remission of diabetes.

Paid-up subscribersThis article can be accessed only if you are a paid-up subscriber to The Practitioner.